ETRUVORT Trademark

Trademark Overview

On Thursday, June 27, 2019, a trademark application was filed for ETRUVORT with the United States Patent and Trademark Office. The USPTO has given the ETRUVORT trademark a serial number of 88491698. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, January 30, 2024. This trademark is owned by Arena Pharmaceuticals, Inc.. The ETRUVORT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, and autoimmune diseases

General Information

Serial Number88491698
Word MarkETRUVORT
Filing DateThursday, June 27, 2019
Status601 - ABANDONED - EXPRESS
Status DateTuesday, January 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of the gastrointestinal tract, Crohn's disease, irritable bowel syndrome, and autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 8, 2019
Primary Code005
First Use Anywhere DateTuesday, August 16, 2022
First Use In Commerce DateTuesday, August 16, 2022

Trademark Owner History

Party NameArena Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NameArena Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, July 1, 2019NEW APPLICATION ENTERED
Monday, July 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 1, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, August 8, 2019ASSIGNED TO LIE
Tuesday, August 13, 2019PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, September 18, 2019ASSIGNED TO EXAMINER
Monday, September 23, 2019PRIORITY ACTION WRITTEN
Monday, September 23, 2019PRIORITY ACTION E-MAILED
Monday, September 23, 2019NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, March 18, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 18, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, March 18, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 18, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, March 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 16, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 14, 2020SOU TEAS EXTENSION RECEIVED
Monday, December 14, 2020SOU EXTENSION 1 FILED
Monday, December 14, 2020SOU EXTENSION 1 GRANTED
Wednesday, December 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 24, 2021SOU TEAS EXTENSION RECEIVED
Monday, May 24, 2021SOU EXTENSION 2 FILED
Monday, May 24, 2021SOU EXTENSION 2 GRANTED
Wednesday, May 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 23, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 23, 2021SOU EXTENSION 3 FILED
Tuesday, November 23, 2021SOU EXTENSION 3 GRANTED
Thursday, November 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 25, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 25, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 27, 2022ASSIGNED TO EXAMINER
Thursday, June 2, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 2, 2022SOU EXTENSION 4 FILED
Thursday, June 2, 2022SOU EXTENSION 4 GRANTED
Saturday, June 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 16, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, September 16, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, September 16, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 16, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, September 16, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 31, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 31, 2022SOU EXTENSION 5 FILED
Monday, November 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 9, 2022SOU EXTENSION 5 GRANTED
Thursday, November 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 1, 2023TEAS STATEMENT OF USE RECEIVED
Monday, May 1, 2023USE AMENDMENT FILED
Monday, May 8, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, May 8, 2023SU - NON-FINAL ACTION - WRITTEN
Monday, May 8, 2023NON-FINAL ACTION E-MAILED
Monday, May 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 25, 2024TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, January 30, 2024ABANDONMENT - EXPRESS MAILED
Tuesday, January 30, 2024ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Tuesday, January 30, 2024ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT

Related Keywords

etruvort diseases disease crohn irritable bowel autoimmune syndrome tract disorders human